Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122216404 | 12221640 | 4 | F | 201601 | 20160802 | 20160330 | 20160808 | EXP | US-PFIZER INC-2015117866 | PFIZER | 62.00 | YR | M | Y | 68.00000 | KG | 20160808 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122216404 | 12221640 | 1 | PS | VFEND | VORICONAZOLE | 1 | Oral | 200 MG, 2X/DAY (12 HOURS APART) | F020930 | 21266 | 200 | MG | FILM-COATED TABLET | BID | |||||
122216404 | 12221640 | 2 | SS | VFEND | VORICONAZOLE | 1 | 21266 | FILM-COATED TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122216404 | 12221640 | 1 | Pneumonia |
122216404 | 12221640 | 2 | Viral infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122216404 | 12221640 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122216404 | 12221640 | Dyspnoea | |
122216404 | 12221640 | Infection | |
122216404 | 12221640 | Lower respiratory tract infection viral | |
122216404 | 12221640 | Lung infection | |
122216404 | 12221640 | Rib fracture | |
122216404 | 12221640 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122216404 | 12221640 | 1 | 2015 | 0 |